What Are Risk Factors for Progression To Severe Disease with Bronchiolitis?
Discussion
Bronchiolitis is a clinical disease with following features: begins usually with rhinitis and cough that may progress to also having tachypnea, rales, wheezing and increased work of breathing shown by nasal flaring and/or accessory muscle use. The increased work of breathing may cause problems with feeding and hydration and also with mental status changes. It is usually seen in infants and children < 2 years of age. It is also usually seasonal (winter in upper North America) with 60-70% of cases being caused by respiratory syncytial virus but also human rhinorvirus, human metapneumovirus, influenza, adenoviru...
Source: PediatricEducation.org - December 15, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Prescription Medications Can Be Found on Craigslist
Advertisements found for insulin and albuterol, with analog insulin the most commonly advertised product (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Endocrinology, Family Medicine, Internal Medicine, Allergy, Emergency Medicine, Pharmacy, Pulmonology, Journal, Source Type: news
Is Enterovirus D68 A New Virus?
Discussion
Enteroviral infections are RNA viruses including Coxsackieviruses A and B, Echoviruses and Enteroviruses. They are common and spread by respiratory secretions, fecal-oral contamination and fomites. They commonly occur in summer and fall in temperate climates but are less seasonally seen in the tropics. Hand hygiene is especially important to prevent infection. The incubation period is usually 3-6 days. The viruses are best isolated from the throat, stool and rectal swab specimens but other infectious sites can also be used for viral isolation. Treatment is supportive. Infants, children and teens are more likely ...
Source: PediatricEducation.org - October 20, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Albuterol side effects: Can I avoid them?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - October 15, 2014 Category: Consumer Health News Source Type: news
8 common child health myths busted
Meaghan O’Keeffe, RN, BSN, is a mother, writer and nurse. She worked at Boston Children’s Hospital for nearly a decade, in both the Cardiac Intensive Care Unit and the Pre-op Clinic. She is a regular contributor to Thriving.
From fever to flu to vaccines and enterovirus, there’s so much health information out there. It’s difficult to separate fact from fiction. Some commonly circulating health myths might confuse even the most well-intentioned parent. Sort out the truth from the myth, and you’re on your way to making the best, informed health care decisions for your child.
Myth: Kids don’t need the flu vaccin...
Source: Thrive, Children's Hospital Boston - October 6, 2014 Category: Pediatrics Authors: Meaghan O'Keeffe Tags: All posts health myths Meaghan O'Keefe Source Type: news
How Much Cetirizine Can Be Used?
Discussion
Antihistamine medications have been available for over 70 years. The original H1-antihistamines, while effective in treated allergic rhinitis, urticaria and other allergic problems, easily penetrated the blood-brain barrier and caused somnolence. The newer, second generation H1-antihistamines have much less somnolent side effects because of poor penetrance.
Fexofenadine (Allegra®), desloratadine (Claritin®) and levocetirizine (Zyrtec®) are commonly used H1-antihistamines in the US today. Previously Astemazole (Hismanal®) and Terfanadine (Seldane®) were used but were withdrawn because of prob...
Source: PediatricEducation.org - July 7, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Albuterol Mist Linked to High Lactate Levels (CME/CE)
(MedPage Today) -- Nebulized albuterol often raised serum lactate levels, but apparently without hurting clinical outcomes, a trial substudy showed. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - January 8, 2014 Category: Pediatrics Source Type: news
Company Recalls Generic Albuterol
(MedPage Today) -- Nephron Pharmaceuticals has recalled 10 lots of albuterol for nebulizers because of possible problems with aseptic processing, according to a company release posted on the FDA website. (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - October 18, 2013 Category: Respiratory Medicine Source Type: news
Inhaled Albuterol Recalled (FREE)
By the Editors
Ten lots of albuterol inhalation solution (0.083%) are being voluntarily recalled "as a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 18, 2013 Category: Primary Care Source Type: news
Ten Lots of Albuterol Inhalation Solution RecalledTen Lots of Albuterol Inhalation Solution Recalled
Nephron Pharmaceuticals says the recall is a precautionary measure stemming from an internal quality monitoring check; no adverse events reported to date. News Alerts (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2013 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news
Albuterol Sulfate Inhalation Solution, 0.083 percent (Nephron Pharmaceuticals): Recall - Aseptic Processing Simulation Results
Finding of bacterial growth. (Source: FDA MedWatch)
Source: FDA MedWatch - October 17, 2013 Category: American Health Source Type: news
Nephron Pharmaceuticals Corporation Announces Voluntary Recall of Albuterol Sulfate Inhalation Solution, 0.083%
Nephron Pharmaceuticals Corporation (NPC) has initiated a voluntary recall, at the retail level, as a precautionary measure, due to results from our internal monitoring processes. NPC is asking retailers to remove the affected lots from store shelves and is asking consumers to discontinue use and dispose of any product they may have that is included in this recall. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 17, 2013 Category: Food Science Source Type: news
What Causes Hypercalcemia?
Discussion
Calcium homeostasis is regulated by mechanisms involving the absorption from the gastrointestinal tract, bone deposition and resorption, and renal excretion. To review Vitamin D homeostasis click here.
Serum calcium is found in three forms: free (47%), protein bound (43%) and diffusable calcium complexes (10%). The protein binding proteins are albumin (80%) and globulin (20%). The free calcium is the most important biologically. Acidosis also increases free calcium and alkalosis decreases free calcium.
Problems associated with hypercalcemia include nausea, emesis, abdominal pain, constipation, polyuria, dehydra...
Source: PediatricEducation.org - March 25, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news
Is nebulized naloxone beneficial in heroin-induced bronchospasm?
2.5 out of 5 stars
The effect of prehospital nebulized naloxone on suspected heroin-induced bronchospasm. Tataris KL et. Am J Emerg Med 2013 Feb 1. [Epub ahead of print]
Abstract
Heroin can induce bronchospasm, probably through the release of histamine. This very brief observational study — from Chicago EMS services — reports on prehospital patients treated with nebulized naloxone for suspected heroin-induced bronchospasm. Data was extracted from paramedic run sheets.
Eligible patients had spontaneous respiration and were treated with nebulized naloxone, 2 mg in 3 ml normal saline. Nineteen cases were identified. Of ...
Source: The Poison Review - February 13, 2013 Category: Toxicology Authors: Leon Tags: Medical bronchospasm heroin nebulized naloxone opiates Source Type: news
ProAir HFA (albuterol sulfate) with Dose Counter Now Available to Patients
NORTH WALES, Pa.--(BUSINESS WIRE)--Jan 3, 2013 - Teva
Respiratory announced today the availability of
ProAir® HFA with dose counter for use in patients 4
years of age and older, for the treatment or prevention of
bronchospasm with reversible... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 3, 2013 Category: Pharmaceuticals Source Type: news
